Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China · Delayed Price · Currency is CNY 4.270
+0.070 (1.67%)
Feb 4, 2026, 3:00 PM CST
SHA:600488 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 16.3 | 133.45 | 117.05 | 35.41 | 48.67 | 33.98 |
Depreciation & Amortization | 289.28 | 289.28 | 271.09 | 257.07 | 205.27 | 183.75 |
Other Amortization | 7.56 | 7.56 | 1.82 | 0.15 | 4.04 | 0.51 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | -0.65 | 0.94 | 0.02 | 0.18 |
Asset Writedown & Restructuring Costs | 45.67 | 45.67 | 51.42 | 136.53 | 56.26 | 0.03 |
Loss (Gain) From Sale of Investments | 9.09 | 9.09 | 1.13 | 22.44 | -4.99 | 1.22 |
Provision & Write-off of Bad Debts | - | - | -0.02 | 0.02 | -0.26 | -0.17 |
Other Operating Activities | -251.25 | 52.55 | 21.43 | -35.94 | 55.56 | 135.18 |
Change in Accounts Receivable | 77.31 | 77.31 | -163.08 | 87.75 | -210.34 | -257.56 |
Change in Inventory | 95 | 95 | 431.73 | -194.44 | 126.07 | 216.04 |
Change in Accounts Payable | -152.15 | -152.15 | 52.22 | 351.63 | 34.88 | 30.21 |
Operating Cash Flow | 148.41 | 569.37 | 783.01 | 653.52 | 316.89 | 346.88 |
Operating Cash Flow Growth | -80.77% | -27.28% | 19.81% | 106.23% | -8.65% | 8.51% |
Capital Expenditures | -69.23 | -77.74 | -133.15 | -202.2 | -370.84 | -458.51 |
Sale of Property, Plant & Equipment | 8.25 | 1.95 | 1.03 | 4.07 | 0.68 | 0.39 |
Cash Acquisitions | - | - | - | - | -10.17 | -140.03 |
Divestitures | -0.4 | -0.4 | - | - | - | - |
Investment in Securities | -20.4 | - | - | - | - | - |
Other Investing Activities | 2.09 | - | - | - | 3.37 | 14 |
Investing Cash Flow | -79.69 | -76.19 | -132.12 | -198.13 | -376.96 | -584.14 |
Short-Term Debt Issued | - | - | - | 155 | 175 | 233.05 |
Long-Term Debt Issued | - | 780.49 | 580.5 | 1,098 | 1,527 | 2,065 |
Total Debt Issued | 326.61 | 780.49 | 580.5 | 1,253 | 1,702 | 2,298 |
Short-Term Debt Repaid | - | - | -77 | -30 | -303.05 | -58 |
Long-Term Debt Repaid | - | -1,229 | -995.57 | -1,185 | -1,229 | -1,978 |
Total Debt Repaid | -407.67 | -1,229 | -1,073 | -1,215 | -1,532 | -2,036 |
Net Debt Issued (Repaid) | -81.06 | -448.37 | -492.07 | 38.09 | 169.23 | 261.63 |
Issuance of Common Stock | - | - | - | - | - | 20.56 |
Repurchase of Common Stock | -4.77 | -4.77 | -5.78 | -8.69 | -1.74 | -0 |
Common Dividends Paid | -87.15 | -123.37 | -47.75 | -60.26 | -58.22 | -81.05 |
Other Financing Activities | -73.2 | -41 | -19.25 | -23.71 | -16.58 | -26.76 |
Financing Cash Flow | -246.18 | -617.52 | -564.85 | -54.57 | 92.69 | 174.37 |
Foreign Exchange Rate Adjustments | 4.68 | 15.89 | 8.17 | 0.59 | 1.33 | -2.43 |
Net Cash Flow | -172.78 | -108.44 | 94.2 | 401.41 | 33.95 | -65.32 |
Free Cash Flow | 79.18 | 491.63 | 649.86 | 451.33 | -53.95 | -111.63 |
Free Cash Flow Growth | -88.32% | -24.35% | 43.99% | - | - | - |
Free Cash Flow Margin | 2.76% | 15.29% | 17.18% | 12.23% | -1.44% | -3.58% |
Free Cash Flow Per Share | 0.07 | 0.45 | 0.59 | 0.41 | -0.05 | -0.10 |
Cash Interest Paid | - | - | - | 4.83 | 0.92 | 5.62 |
Cash Income Tax Paid | 110.41 | 139.86 | 194.44 | 167.01 | 147.23 | 131.61 |
Levered Free Cash Flow | 59.41 | 433.66 | 480.9 | 427.86 | -78.42 | 35.8 |
Unlevered Free Cash Flow | 72.69 | 451.67 | 503.82 | 457.96 | -49.73 | 60.92 |
Change in Working Capital | 31.73 | 31.73 | 319.75 | 236.91 | -47.67 | -7.8 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.